《Table 1 Characteristics of the included studies》

《Table 1 Characteristics of the included studies》   提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《中草药对治疗癌症恶病质动物模型有效性的系统性回顾（英文）》


  1. 获取 高清版本忘记账户？点击这里登录
  1. 下载图表忘记账户？点击这里登录
↓:significantly decrease as the compared with the control group；↑:significantly increase as compared with the control group；n.s.:no significant difference；IL:interleukin；5-FU:5-fluorouracil；QSYQT:Qing-Shu-Yi-Qi-Tang；TNF-α:tumor necrosis factor-α；NF-κB

The characteristics of the included studies are summarized in Table 1.Nine studies were performed with mice and four studies used rats.A total of eight techniques were used for cancer cachectic models.Wistar rats with AH-130 hepatoma cells and C57BL/6mice with Lewis lung carcinoma were used the most frequently and were each used in three studies.A total of fourteen herbal medicines or their compounds were explored.Of them，Rikkunshito（RKT）was investigated the most and was used in three trials，and Qing-Shu-Yi-Qi-Tang（QSYQT）was studied the second most frequently，in two studies.

图表编号XD0047004100    严禁用于非法目的
绘制时间2019.01.03
作者Bongki PARK、Sooseong YOU、William C.S.CHO、Jun-Yong CHOI、Myeong Soo LEE
绘制单位Liver and Immunology Research Center, Oriental College, Daejeon University、Clinical Medicine Division, Korea Institute of Oriental Medicine、Department of Clinical Oncology, Queen Elizabeth Hospital、Department of Korean Internal Medicine, School of Korean
更多格式高清、无水印（增值服务）

相关图表

  1. 《Table 1 Summary of the main characteristics of the 4 studies included in the meta-analysis》2018.06.01
  2. 《Table 1 Characteristics of the studies included in the meta-analysis》2019.05.21
  3. 《表1 纳入文献特征表Tab 1 The characteristics of included studies》2019.02.20
  4. 《Table 1 Characteristics of included studies:Evaluating vitamin D treatment in children with inflammatory bowel disease》2019.01.22
  5. 《Table 1 Population, intervention, comparison and outcome characteristics of included studies》2019.04.30
  6. 《Table 1 Population, intervention, comparison and outcome characteristics of included studies》2019.04.30
  7. 《Table 1 Characteristics of the included studies》2019.01.03
  8. 《Table.General characteristics of studies on DCAG regimen included in the Meta-analysis》2019.04.20
  9. 《Table 1.Study characteristics for the included studies.》2019.04.01
  10. 《Table 1 General characteristics of included studies》2019.02.20
  11. 《Table 2 Key characteristics of the included studies》2019.03.18
  12. 《Table 1 Key characteristics of the included studies》2019.03.18
  13. 《表1 纳入文献基本特征Tab.1 Characteristics of the studies included in the Meta-analysis》2019.03.05
  14. 《Table 1.Main Characteristics of the Included Studies》2019.03.20
  15. 《Table 2 The main characteristics of the included studies on the relationship of NLR and PLR to DR》2019.02.18
  16. 《Table 1 The main characteristics of the included studies on DR》2019.02.18
  17. 《Table 1 The general characteristics of included studies》2019.02.18
  18. 《表1 纳入文献的一般情况Tab.1 Characteristics of the included studies》2018.12.19
  19. 《Table 1Characteristics of the studies included in the meta-analysis.》2018.12.15
  20. 《Table 1Baseline characteristics of included patients in the study (n=18 948) .》2018.02.01

随机翻阅

《表2 扫描次数对不同含水率样品核磁信号信噪比的影响》 《表4 各变量平稳性检验：玉溪市某镇污水处理厂改造工程实例》 《表2 煤层物理特性参数及脉动频率》 《表3 方差分析：伤科消肿止痛膏制备工艺以及有效成分含量测定》 《表1 两组患者诊断准确率对比分析》 《表3 不同粒径下单个环节拟合度》 《表5 不同离势系数对应总体均值的置信区间》 《表1 超声BI-RADS分类与病理结果比较[n (%) ]》 《表1 两组豚鼠超声心动图及心电图的资料》 《表2 贡献率与累计贡献率》